Human Papillomavirus Type 16 Oropharyngeal Cancers in Lymph Nodes as a Marker of Metastases | Head and Neck Cancer | JAMA Otolaryngology–Head & Neck Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer.  Oral Oncol. 2009;45(4-5):309-31618804401PubMedGoogle ScholarCrossref
2.
Mork J, Lie AK, Glattre E,  et al.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.  N Engl J Med. 2001;344(15):1125-113111297703PubMedGoogle ScholarCrossref
3.
Dahlstrom KR, Adler-Storthz K, Etzel CJ,  et al.  Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis.  Clin Cancer Res. 2003;9(7):2620-262612855639PubMedGoogle Scholar
4.
Gillison ML, Koch WM, Capone RB,  et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.  J Natl Cancer Inst. 2000;92(9):709-72010793107PubMedGoogle ScholarCrossref
5.
Lim YC, Koo BS, Lee JS, Lim JY, Choi EC. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.  Laryngoscope. 2006;116(7):1148-115216826050PubMedGoogle ScholarCrossref
6.
Youssef E, Chuba P, Salib N,  et al.  Pathological distribution of positive lymph nodes in patients with clinically and radiologically N0 oropharyngeal carcinoma: implications for IMRT treatment planning.  Cancer J. 2005;11(5):412-41616259872PubMedGoogle ScholarCrossref
7.
Hoffmann M, Orlamünder A, Sucher J,  et al.  HPV16 DNA in histologically confirmed tumour-free neck lymph nodes of head and neck cancers.  Anticancer Res. 2006;26(1B):663-67016739336PubMedGoogle Scholar
8.
Begum S, Gillison ML, Nicol TL, Westra WH. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.  Clin Cancer Res. 2007;13(4):1186-119117317828PubMedGoogle ScholarCrossref
9.
Begum S, Gillison ML, Ansari-Lari MA, Shah K, Westra WH. Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.  Clin Cancer Res. 2003;9(17):6469-647514695150PubMedGoogle Scholar
10.
Zhang MQ, El-Mofty SK, Dávila RM. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary.  Cancer. 2008;114(2):118-12318300234PubMedGoogle ScholarCrossref
11.
El-Mofty SK, Zhang MQ, Davila RM. Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma.  Head Neck Pathol. 2008;2(3):163-16820614311PubMedGoogle ScholarCrossref
12.
Robbins KT, Clayman G, Levine PA,  et al; American Head and Neck Society; American Academy of Otolaryngology–Head and Neck Surgery.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery.  Arch Otolaryngol Head Neck Surg. 2002;128(7):751-75812117328PubMedGoogle Scholar
13.
Desai PC, Jaglal MV, Gopal P,  et al.  Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: a retrospective 7 year study.  Exp Mol Pathol. 2009;87(2):94-9819393644PubMedGoogle ScholarCrossref
14.
Chan PK, Yu MM, Cheung TH,  et al.  Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma.  J Clin Virol. 2005;33(3):201-20515911441PubMedGoogle ScholarCrossref
15.
Coutant C, Barranger E, Cortez A,  et al.  Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer.  Ann Oncol. 2007;18(9):1513-151717761707PubMedGoogle ScholarCrossref
16.
Burnett AF, Barnes WA, Johnson JC,  et al.  Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer.  Gynecol Oncol. 1992;47(3):343-3471335431PubMedGoogle ScholarCrossref
17.
Nawa A, Nishiyama Y, Kikkawa F,  et al.  Detection of human papillomaviruses from histologically normal lymph nodes of Japanese cervical cancer patients by nested polymerase chain-reaction assay.  Int J Cancer. 1993;53(6):932-9378386139PubMedGoogle ScholarCrossref
18.
Kobayashi Y, Yoshinouchi M, Tianqi G,  et al.  Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes.  Clin Cancer Res. 1998;4(4):979-9839563893PubMedGoogle Scholar
19.
Hernádi Z, Szarka K, Sápy T, Krasznai Z, Veress G, Póka R. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.  BJOG. 2003;110(2):205-20912618167PubMedGoogle ScholarCrossref
20.
Lukaszuk K, Liss J, Wozniak I, Sliwinski W, Emerich J, Wojcikowski C. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study.  J Clin Pathol. 2004;57(5):472-47615113853PubMedGoogle ScholarCrossref
21.
Rolla M, Berretta R, Patrelli TS,  et al.  A perspective study on correlation between HPV DNA and lymph nodes in surgically treated cervical carcinoma patients: preliminary data.  Eur J Gynaecol Oncol. 2009;30(5):557-56119899415PubMedGoogle Scholar
22.
Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer.  J Clin Pathol. 2002;55(4):244-26511919208PubMedGoogle ScholarCrossref
23.
Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.  CMAJ. 2001;164(7):1017-102511314432PubMedGoogle Scholar
24.
Tao L, Lefèvre M, Ricci S,  et al.  Detection of occult carcinomatous diffusion in lymph nodes from head and neck squamous cell carcinoma using real-time RT-PCR detection of cytokeratin 19 mRNA.  Br J Cancer. 2006;94(8):1164-116916622440PubMedGoogle ScholarCrossref
25.
Xu Y, Lefèvre M, Périé S,  et al.  Clinical significance of micrometastases detection in lymph nodes from head and neck squamous cell carcinoma.  Otolaryngol Head Neck Surg. 2008;139(3):436-44118722227PubMedGoogle ScholarCrossref
Original Article
Sep 2011

Human Papillomavirus Type 16 Oropharyngeal Cancers in Lymph Nodes as a Marker of Metastases

Author Affiliations

Author Affiliations: Departments of Otolaryngology–Head and Neck Surgery (Drs Mirghani, Périé, and St Guily), Virology (Drs Moreau and Soussan and Ms Tam), and Pathology (Dr Lefèvre), Faculty of Medicine, University Pierre et Marie Curie Paris VI and Hospital Tenon Assistance Publique Hôpitaux de Paris, Paris, France.

Arch Otolaryngol Head Neck Surg. 2011;137(9):910-914. doi:10.1001/archoto.2011.141
Abstract

Background Oropharyngeal squamous cell carcinomas (OSCCs) are associated with high-grade human papillomavirus (HPV) infection in 20% to 30% of cases. HPV-16 DNA has been detected in cervical lymph node metastases of HPV-16+ OSCC. However, the meaning of HPV-16 DNA detection in lymph nodes remains controversial. Does the presence of HPV-16 DNA in lymph nodes correlate with their metastatic involvement, or is it just a consequence of the filter function of lymph nodes?

Methods Viral load quantification using reverse transcriptase–polymerase chain reaction was retrospectively performed in primary tumors and in cervical lymph nodes, originating from levels IIa, IIb, and III, in 11 patients with HPV-16+ OSCC and in 3 control patients with HPV-16 OSCC.

Results A total of 45 lymph node levels were analyzed. HPV-16 DNA was not detected in HPV-16 OSCC lymph nodes. No statistically significant difference was found between primary tumors and metastatic lymph nodes viral load (P >> .01). The viral load value was significantly higher in metastatic lymph nodes than in tumor-free lymph nodes (P < .01). Among 27 tumor-free lymph node levels, the viral load value was undetectable in 16, low or medium (<105 copies per million cells) in 8, and high (>105 copies per million cells) in 3.

Conclusions HPV-16 DNA detection in lymph nodes of patients affected with HPV-16+ oropharyngeal cancer is indicative of metastatic involvement. Tumor-free lymph nodes with a high viral load value would suggest the presence of occult lymph nodes metastasis and the opportunity to use HPV-16 DNA as a metastatic marker. Further investigations are needed.

×